Explore research-focused peptide articles designed to make complex compounds, safety considerations, and emerging peptide science easier to understand.
5-Amino-1MQ (5-Amino-1-Methylquinolinium): The Investigational Small-Molecule NNMT Inhibitor With Preclinical Anti-Obesity Evidence and No Confirmed Human Clinical Trials Despite Widespread Marketing Claims By Medical Team of Generic Peptides 5-Amino-1MQ is a…
Retatrutide (LY3437943): The Investigational First-in-Class Triple GIP/GLP-1/Glucagon Receptor Agonist With 28.7% Weight Loss in Phase 3 TRIUMPH-4 and the Dysesthesia Signal Defining Its Safety Profile By Medical Team of Generic Peptides Retatrutide (LY343794…
Tirzepatide (Mounjaro / Zepbound): The First-in-Class Dual GIP/GLP-1 Receptor Agonist With FDA-Approved T2DM, Obesity, and Sleep Apnea Indications and Superior Weight Loss to Semaglutide in 2025 SURMOUNT-5 By Medical Team of Generic Peptides Tirzepatide (LY32…
Thymosin Alpha-1 (Thymalfasin / Zadaxin): The 28-Amino-Acid Synthetic Thymic Peptide With 35+ Country Approval, Definitive 2025 Phase III Sepsis Trial Failure, and Complicated December 2024 PCAC Negative Vote By Medical Team of Generic Peptides Thymosin Alpha…
Thymalin (Тималин): The Russian-Approved Polypeptide Complex From Calf Thymus With 1982 Registration, 40+ Year Clinical History, and Critical Methodological Considerations By Medical Team of Generic Peptides Thymalin is a polypeptide complex extracted from ca…
Tesamorelin (Egrifta / Egrifta SV / Egrifta WR): The FDA-Approved GHRH Analog for HIV-Associated Lipodystrophy With March 2025 New Formulation Approval and Investigational NAFLD Applications By Medical Team of Generic Peptides Tesamorelin is a synthetic 44-am…
TB-500 (Thymosin Beta-4 Fragment): The Synthetic Wound-Healing Peptide With July 23, 2026 PCAC Review and the Critical Distinction From Full Thymosin Beta-4 Clinical Evidence By Medical Team of Generic Peptides TB-500 is a synthetic peptide representing the a…
Somatropin: The FDA-Approved Recombinant Human Growth Hormone With Multiple Indications, Long-Acting Weekly Formulations, and Distinct Positioning From Peptide Secretagogues By Medical Team of Generic Peptides Somatropin is recombinant human growth hormone (r…
Sermorelin (GHRH 1-29 / Geref): The Historically FDA-Approved GHRH Analog With Legitimate Compounding Pharmacy Pathway and 30-Year Clinical Track Record By Medical Team of Generic Peptides Sermorelin acetate is a synthetic 29-amino-acid polypeptide representi…
Semax: The Russian-Approved ACTH(4-7) Analog Heptapeptide on the July 2026 PCAC Agenda for Cerebral Ischemia, Migraine, and Trigeminal Neuralgia By Medical Team of Generic Peptides Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pr…
Semaglutide (Ozempic, Wegovy, Rybelsus): The FDA-Approved GLP-1 Receptor Agonist With Multiple Indications, Robust Phase 3 Evidence, and 2025 MASH Approval By Medical Team of Generic Peptides Semaglutide is a synthetic 31-amino-acid GLP-1 receptor agonist ana…
Selank: The Russian-Approved Anxiolytic Heptapeptide With Tuftsin-Derived Structure and Specific 2024-2026 Regulatory Limbo By Medical Team of Generic Peptides Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Molecul…